Biosante Pharmaceuticals Aktie

Biosante Pharmaceuticals für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN DE: A1W15D / ISIN: US00182C1036

<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>
<
Aktion
Portfolio
Watchlist
>
07.08.2026 13:00:05

ANI Pharmaceuticals, Inc. Profit Climbs In Q2

(RTTNews) - ANI Pharmaceuticals, Inc. (ANIP) revealed earnings for its second quarter that Increases, from the same period last year

The company's bottom line came in at $24.71 million, or $1.05 per share. This compares with $8.14 million, or $0.36 per share, last year.

Excluding items, ANI Pharmaceuticals, Inc. reported adjusted earnings of $47.63 million or $2.21 per share for the period.

The company's revenue for the period rose 25.9% to $266.04 million from $211.37 million last year.

ANI Pharmaceuticals, Inc. earnings at a glance (GAAP) :

-Earnings: $24.71 Mln. vs. $8.14 Mln. last year. -EPS: $1.05 vs. $0.36 last year. -Revenue: $266.04 Mln vs. $211.37 Mln last year.

-Guidance: Full year EPS guidance: $ 9.19 To $ 9.69 Full year revenue guidance: $ 1.080 B To $ 1.140 B

Analysen zu Biosante Pharmaceuticals Inc

mehr Analysen
Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Biosante Pharmaceuticals Inc 65,50 -8,39% Biosante Pharmaceuticals Inc